112
Participants
Start Date
November 21, 2016
Primary Completion Date
April 30, 2021
Study Completion Date
August 1, 2023
BI 754091
Greenville Health System, Greenville
Florida Cancer Specialists, Sarasota
Tennessee Oncology, PLLC, Nashville
Karmanos Cancer Institute, Detroit
Ingalls Memorial Hospital, Harvey
Stephenson Cancer Center, Oklahoma City
The University of Texas MD Anderson Cancer Center, Houston
Juravinski Cancer Centre - Hamilton Health Sciences, Hamilton
The Ottawa Hospital, Ottawa
Princess Margaret Cancer Centre, Toronto
Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal
Sarah Cannon Research Institute, London
The Christie Hospital, Manchester
Lead Sponsor
Boehringer Ingelheim
INDUSTRY